Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-06 · accession 0000950170-25-067237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-08 | 2025-05-06+ | PHAT | Parikh Asit | Dir | P - Purchase | $2.50 | +10.0K | 95.5K | +12% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-06 | P | A | 5,000 | $2.60 | 90,500 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-07 | P | A | 5,000 | $2.40 | 95,500 | D | — | — |